Find and Pitch Jounalists, Get Your Story Covered

Tags: cancer metformin myeloid leukemia burn scars marjolin's ulcer

	Profile	Recent Articles on Subject
1	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Crisis in CRISPR world, RFK Jr.’s promises, and a novel non-opioid pain drug - 24 days ago
2	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Crisis in CRISPR world, RFK Jr.’s promises, and a novel non-opioid pain drug - 24 days ago In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease - about 1 year ago
3	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: The CRISPR companies are not OK - 25 days ago STAT+: Scribe Therapeutics becomes latest CRISPR company to announce layoffs - about 2 months ago STAT+: Editas Medicine lays off 65% of staff and shelves lead gene-editing program - 3 months ago STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution - about 1 year ago STAT+: Feng Zhang’s year-old CRISPR delivery startup Aera lays off quarter of staff - about 1 year ago STAT+: After decade-long dispute over CRISPR-Cas9, Editas strikes deal with Vertex to cash in - about 1 year ago STAT+: How sickle cell became the first disease treated by CRISPR - about 1 year ago STAT+: In major test for prime editing, scientists successfully correct mutations in monkeys - over 1 year ago STAT+: David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells - over 1 year ago
4	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	4 companies to watch in the accelerating gene editing race - about 2 months ago The FDA just approved the first CRISPR drug. Here’s what’s next in gene editing. - about 1 year ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	More beef in the gene editing space - 3 months ago What happens when an approved drug doesn’t work? - 12 months ago A new algorithm unveils CRISPR ‘treasure trove’ - over 1 year ago
6	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	23andMe inches closes to cancer immunotherapy, guided by its genetic database - 6 months ago This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain - about 1 year ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago
7	Danielle Gerhard, PhD The Scientist Assistant Editor @TheScientistLLC. United Kingdom scienceediting	A CRISPR Tool for Tinkering with the Human Transcriptome - 7 months ago All Roads Lead to Genome Editing - about 1 year ago All Roads Lead to Genome Editing - about 1 year ago
8	Jesse Klein GreenBiz Comedian. Woodsman. comedy	Why Bayer and the Gates Foundation are using CRISPR to reduce food's climate impact - 11 months ago
9	Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto ScienceFreelance Writing	CRISPR Gene Drives and the Future of Evolution - 12 months ago
10	Elie Dolgin Nature Science journalist. Writes for eliedolgin.com. Somerville, Massachusetts science journalism	Stealthy stem cells to treat disease - about 1 year ago

Journalists covering cancer, careers, CRISPR, gene editing, genetics, mentoring, zinc finger nuclease